Description

Retatrutide is a synthetic peptide designed to interact with multiple metabolic signaling receptors, including those associated with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon pathways. In laboratory and pre-clinical research, retatrutide has been studied for its role in metabolic signaling, energy balance, and glucose regulation pathways.

Researchers use retatrutide to examine how multi-receptor peptide activity influences cellular metabolism, insulin signaling, and energy utilization. Its triple-agonist structure makes it a compound of interest in studies focused on metabolic regulation, endocrine communication, and nutrient-response signaling.

For research use only.

This compound is not approved for human or veterinary use and is intended exclusively for in-vitro and laboratory research conducted by qualified professionals.